The therapeutic armamentarium for heart failure with preserved ejection fraction (HFpEF) remains notably constrained. A factor contributing to this problem could be the scarcity of in vitro models for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback